Teva Pharmaceutical Industries Current Ratio 2006-2018 | TEVA

Current and historical current ratio for Teva Pharmaceutical Industries (TEVA) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Teva Pharmaceutical Industries current ratio for the three months ending December 31, 2018 was 0.96.
Teva Pharmaceutical Industries Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $13.79B $14.32B 0.96
2018-09-30 $13.88B $14.83B 0.94
2018-06-30 $14.71B $14.22B 1.04
2018-03-31 $14.69B $14.76B 1.00
2017-12-31 $15.38B $17.92B 0.86
2017-09-30 $16.23B $16.94B 0.96
2017-06-30 $14.60B $15.46B 0.94
2017-03-31 $14.84B $15.90B 0.93
2016-12-31 $17.23B $18.49B 0.93
2016-09-30 $17.39B $19.29B 0.90
2016-06-30 $18.34B $14.41B 1.27
2016-03-31 $16.99B $12.91B 1.32
2015-12-31 $18.40B $13.01B 1.42
2015-09-30 $12.50B $12.98B 0.96
2015-06-30 $13.30B $14.47B 0.92
2015-03-31 $15.71B $12.47B 1.26
2014-12-31 $14.40B $12.29B 1.17
2014-09-30 $13.92B $11.67B 1.19
2014-06-30 $13.55B $11.85B 1.14
2014-03-31 $13.45B $11.40B 1.18
2013-12-31 $13.72B $11.97B 1.15
2013-09-30 $13.91B $12.16B 1.14
2013-06-30 $14.09B $12.84B 1.10
2013-03-31 $14.42B $12.36B 1.17
2012-12-31 $16.36B $12.89B 1.27
2012-09-30 $14.98B $10.63B 1.41
2012-06-30 $14.23B $10.01B 1.42
2012-03-31 $14.97B $13.63B 1.10
2011-12-31 $14.45B $13.68B 1.06
2011-09-30 $13.02B $11.48B 1.13
2011-06-30 $12.60B $10.05B 1.25
2011-03-31 $12.05B $8.89B 1.36
2010-12-31 $12.04B $9.69B 1.24
2010-09-30 $11.86B $9.32B 1.27
2010-06-30 $14.44B $8.18B 1.77
2010-03-31 $12.61B $8.34B 1.51
2009-12-31 $12.14B $7.60B 1.60
2009-09-30 $11.46B $7.23B 1.58
2009-06-30 $11.04B $7.24B 1.52
2009-03-31 $11.14B $8.57B 1.30
2008-12-31 $11.43B $8.48B 1.35
2008-09-30 $10.95B $4.98B 2.20
2008-06-30 $10.82B $5.46B 1.98
2008-03-31 $10.49B $5.75B 1.82
2007-12-31 $9.86B $5.37B 1.84
2007-09-30 $9.13B $5.22B 1.75
2007-06-30 $8.67B $4.74B 1.83
2007-03-31 $8.02B $4.64B 1.73
2006-12-31 $7.64B $4.07B 1.88
2006-09-30 $7.24B $3.94B 1.84
2006-06-30 $6.67B $3.99B 1.67
2006-03-31 $5.86B $3.68B 1.59
2005-12-31 $5.51B $2.26B 2.44
2005-09-30 $4.40B $2.17B 2.03
2005-06-30 $4.26B $2.09B 2.04
2005-03-31 $4.25B $2.19B 1.94
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $15.162B $18.854B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $47.288B 8.51
Mylan (MYL) United Kingdom $13.724B 5.81
Bausch Health Cos (BHC) Canada $8.210B 5.84
Dr Reddy's Laboratories (RDY) India $6.790B 27.08
Supernus Pharmaceuticals (SUPN) United States $1.951B 18.10
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.534B 2.49
Amphastar Pharmaceuticals (AMPH) United States $0.979B 90.43
Homology Medicines (FIXX) United States $0.873B 0.00
CymaBay Therapeutics (CBAY) United States $0.742B 0.00
Voyager Therapeutics (VYGR) United States $0.677B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.429B 0.00
Assembly Biosciences (ASMB) United States $0.389B 0.00
Akorn (AKRX) United States $0.374B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.209B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.175B 0.00
Sol-Gel Technologies (SLGL) Israel $0.133B 0.00
Acasti Pharma (ACST) Canada $0.069B 0.00
Agile Therapeutics (AGRX) United States $0.063B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.063B 0.00
Teligent (TLGT) United States $0.053B 0.00
China Pharma Holdings (CPHI) China $0.015B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Evoke Pharma (EVOK) United States $0.012B 0.00